Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

MIMEDX Announces Receipt Of FDA Warning Letter For AXIOFILL Classification, Not Related To Safety; Reiterates 2023 Full Year Net Sales And Fourth Quarter Adjusted EBITDA Margin Outlook

Author: Bill Haddad | December 29, 2023 06:02pm

Posted In: MDXG